Latest Breaking News On - Kangtai - Page 8 : vimarsana.com
《異動股》金斯瑞升逾２０％突破２５０天線，報１４﹒５６元 - 經濟通 ET Net
etnet.com.hk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from etnet.com.hk Daily Mail and Mail on Sunday newspapers.
Airfreight industry reaches for new heights--China Economic Net
en.ce.cn - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from en.ce.cn Daily Mail and Mail on Sunday newspapers.
香港特區政府刊憲12幢疫廈須強檢 分布港九新界
hkcna.hk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from hkcna.hk Daily Mail and Mail on Sunday newspapers.
Shenzhen firm to make 400m AZ doses a year
archive.shine.cn - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from archive.shine.cn Daily Mail and Mail on Sunday newspapers.
2021-02-03 03:39:23 GMT2021-02-03 11:39:23(Beijing Time) Sina English
Shenzhen Kangtai Biological Products said on Tuesday it had completed a facility designed to be able to produce 400 million doses of AstraZeneca’s COVID-19 vaccine per year, doubling a capacity target promised in 2020.
“Kangtai is actively pushing forward procedures for the vaccine’s clinical trial and registration in China, and has completed a manufacturing plant and started trial production,” the Shenzhen-based firm said in a press release.
The firm obtained rights to supply the AZD1222 vaccine, developed by the Anglo-Swedish drugmaker and Oxford University, in China’s mainland last year in return for having capacity to produce at least 200 million doses by the end of 2021.